Miranda E. Pitt
Impact in
- Molecular Medicine top 5%
- Antibiotic Resistance in Bacteria
Papers in
-
- SARS-CoV-2 and COVID-19 Research 4
- Antimicrobial Resistance in Staphylococcus 2
-
- Antibiotic Resistance in Bacteria 4
- Co-authors
- Matthew A. Cooper (7 shared papers)Mark A. T. Blaskovich (7 shared papers)Lachlan Coin (12 shared papers)Alysha G. Elliott (3 shared papers)Minh Duc Cao (3 shared papers)Devika Ganesamoorthy (3 shared papers)Mark S. Butler (2 shared papers)Tania P. S. Duarte (3 shared papers)
- Journals
- Science Translational Medicine (1 paper)Nature Communications (1 paper)Microbiology Spectrum (1 paper)Current Biology (1 paper)GigaScience (1 paper)
- Partner nations
- AustraliaChinaUnited States
In The Last Decade
Miranda E. Pitt
20 papers receiving 422 citations
Miranda E. Pitt's Hit Papers
Peers
Comparison fields: 5 of 49
- Molecular Medicine 98
- Clinical Biochemistry 18
- Microbiology 21
- Infectious Diseases 56
- Endocrinology 10
Countries citing papers authored by Miranda E. Pitt
This map shows the geographic impact of Miranda E. Pitt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Miranda E. Pitt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Miranda E. Pitt more than expected).
Fields of papers citing papers by Miranda E. Pitt
This network shows the impact of papers produced by Miranda E. Pitt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Miranda E. Pitt. The network helps show where Miranda E. Pitt may publish in the future.
Co-authors
The 25 scholars most cited alongside Miranda E. Pitt, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Detection of Streptococcus pyogenes M1UK in Australia and characterization of the mutation driving enhanced expression of superantigen SpeA Hit paper breakdown → | 2023 | 71 |
| 2 | 2018 | 57 | |
| 3 | 2016 | 46 | |
| 4 | 2016 | 39 | |
| 5 | 2020 | 30 | |
| 6 | 2021 | 30 | |
| 7 | 2019 | 23 | |
| 8 | 2022 | 22 | |
| 9 | 2023 | 22 | |
| 10 | 2018 | 19 | |
| 11 | 2018 | 17 | |
| 12 | 2022 | 16 | |
| 13 | 2022 | 15 | |
| 14 | 2023 | 11 | |
| 15 | 2026 | 5 | |
| 16 | 2024 | 4 | |
| 17 | 2025 | 2 | |
| 18 | 2020 | 1 | |
| 19 | 2024 | 1 | |
| 20 | 2025 | 1 |
About Miranda E. Pitt
Miranda E. Pitt is a scholar working on Infectious Diseases, Molecular Medicine, Molecular Biology, Endocrinology and Clinical Biochemistry, having authored 22 papers that have together received 432 indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (4 papers), SARS-CoV-2 and COVID-19 Research (4 papers), Streptococcal Infections and Treatments (2 papers), Antimicrobial Resistance in Staphylococcus (2 papers), Machine Learning in Bioinformatics (2 papers), Burkholderia infections and melioidosis (2 papers), Antimicrobial Peptides and Activities (1 paper) and Origins and Evolution of Life (1 paper). The work is most often cited by research in Molecular Medicine (98 citations), Clinical Biochemistry (18 citations), Microbiology (21 citations), Infectious Diseases (56 citations) and Endocrinology (10 citations). Miranda E. Pitt has collaborated with scholars based in Australia, China and United States. Frequent co-authors include Matthew A. Cooper, Mark A. T. Blaskovich, Lachlan Coin, Alysha G. Elliott, Minh Duc Cao, Devika Ganesamoorthy, Mark S. Butler, Tania P. S. Duarte, Ruby Pelingon and Geraldine Kaeslin. Their work appears in journals such as Science Translational Medicine, Nature Communications, Microbiology Spectrum, Current Biology and GigaScience.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.